Pulmonx Corporation (LUNG) Tops Q3 EPS by 81c, provides guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Nasdaq ends higher as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts LUNG Hot Sheet
Join SI Premium – FREE
Pulmonx Corporation (NASDAQ: LUNG) reported Q3 EPS of $0.36, $0.81 better than the analyst estimate of ($0.45). Revenue for the quarter came in at $20.4 million versus the consensus estimate of $20.29 million.
GUIDANCE:
Pulmonx Corporation sees FY2024 revenue of $81-84 million, versus the consensus of $82.634 million.
For earnings history and earnings-related data on Pulmonx Corporation (LUNG) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- People Incorporated (PPLI) PT Lowered to $47 at Citizens - Shares Meaningfully Undervalue Business
- Mirum Pharmaceuticals (MIRM) PT Raised to $167 at Citizens - One of 'Favorite Rare Disease Names'
- Ashland (ASH) Misses Q4 EPS by 16c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
